Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia

Published:2015-07 Issue:1 Volume:28 Page:114-128
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Shojaee Seyedmehdi,Caeser Rebecca,Buchner Maike,Park Eugene,Swaminathan Srividya,Hurtz Christian,Geng Huimin,Chan Lai N.,Klemm Lars,Hofmann Wolf-Karsten,Qiu Yi Hua,Zhang Nianxiang,Coombes Kevin R.,Paietta Elisabeth,Molkentin Jeffery,Koeffler H. Phillip,Willman Cheryl L.,Hunger Stephen P.,Melnick Ari,Kornblau Steven M.,Müschen Markus

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference35 articles.

1. Relapsed childhood acute lymphoblastic leukaemia;Bhojwani;Lancet Oncol.,2013

2. ERM is required for transcriptional control of the spermatogonial stem cell niche;Chen;Nature,2005

3. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours;Chi;Nature,2010

4. A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias;Cortes;N. Engl. J. Med.,2013

5. A negative feedback signaling network underlies oncogene-induced senescence;Courtois-Cox;Cancer Cell,2006

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ikaros sets the threshold for negative B-cell selection by regulation of the signaling strength of the AKT pathway;Cell Communication and Signaling;2024-07-12

2. DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer;EMBO Molecular Medicine;2024-06-17

3. Concepts in B cell acute lymphoblastic leukemia pathogenesis;Journal of Leukocyte Biology;2024-01-18

4. PI3Kδ Inhibition Potentiates Glucocorticoids in B-lymphoblastic Leukemia by Decreasing Receptor Phosphorylation and Enhancing Gene Regulation;Cancers;2023-12-27

5. Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates;Cancers;2023-12-24